check_circleStudy Completed

Candidiasis, Vulvovaginal

0460_Canesten

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

14 - 66 Years
  • -

  • -

Trial summary

Enrollment Goal
50
Trial Dates
June 1980 - Today
Phase
N/A
Could I Receive a placebo
N/A
Products
Mycelex (Clotrimazole, BAYB5097)
Accepts Healthy Volunteer
N/A

Trial design

Efficacy and tolerance of two galenical product formulations of Canesten vaginal tablets containing 500 mg of the active ingredient clotrimazole after a single administration to patients with vaginal yeast infections.
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A